Viewing Study NCT00897533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2026-03-03 @ 4:24 AM
Study NCT ID: NCT00897533
Status: COMPLETED
Last Update Posted: 2017-05-19
First Post: 2009-05-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent non-small cell lung cancer View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None adenocarcinoma of the lung View
None squamous cell lung cancer View
None bronchoalveolar cell lung cancer View